{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:06:28Z","timestamp":1794413188034,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study evaluates the genetic spectrum of leukodystrophies and leukoencephalopathies in Iran. 152 children, aged from 1\u00a0day to 15\u00a0years, were genetically tested for leukodystrophies and leukoencephalopathies based on clinical and neuroradiological findings from 2016 to 2019. Patients with a suggestive specific leukodystrophy, e. g. metachromatic leukodystrophy, Canavan disease, Tay-Sachs disease were tested for mutations in single genes (108; 71%) while patients with less suggestive findings were evaluated by NGS. 108 of 152(71%) had MRI patterns and clinical findings suggestive of a known leukodystrophy. In total, 114(75%) affected individuals had (likely) pathogenic variants which included 38 novel variants. 35 different types of leukodystrophies and genetic leukoencephalopathies were identified. The more common identified disorders included metachromatic leukodystrophy (19 of 152; 13%), Canavan disease (12; 8%), Tay-Sachs disease (11; 7%), megalencephalic leukodystrophy with subcortical cysts (7; 5%), X-linked adrenoleukodystrophy (8; 5%), Pelizaeus\u2013Merzbacher-like disease type 1 (8; 5%), Sandhoff disease (6; 4%), Krabbe disease (5; 3%), and vanishing white matter disease (4; 3%). Whole exome sequencing (WES) revealed 90% leukodystrophies and genetic leukoencephalopathies. The total diagnosis rate was 75%. This unique study presents a national genetic data of leukodystrophies; it may provide clues to the genetic pool of neighboring countries. Patients with clinical and neuroradiological evidence of a genetic leukoencephalopathy should undergo a genetic analysis to reach a definitive diagnosis. This will allow a diagnosis at earlier stages of the disease, reduce the burden of uncertainty and costs, and will provide the basis for genetic counseling and family planning.<\/jats:p>","DOI":"10.1038\/s41598-021-82778-0","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T11:24:30Z","timestamp":1612524270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Genetic testing of leukodystrophies unraveling extensive heterogeneity in a large cohort and report of five common diseases and 38 novel variants"],"prefix":"10.1038","volume":"11","author":[{"given":"Nejat","family":"Mahdieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Soveizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Reza","family":"Tavasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfried","family":"Kohlsch\u00fctter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"82778_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1212\/WNL.0b013e3181eee46b","volume":"75","author":"JL Bonkowsky","year":"2010","unstructured":"Bonkowsky, J. L. et al. The burden of inherited leukodystrophies in children. Neurology 75, 718\u2013725. https:\/\/doi.org\/10.1212\/WNL.0b013e3181eee46b (2010).","journal-title":"Neurology"},{"key":"82778_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/(SICI)1096-8628(19970905)71:4<475::AID-AJMG20>3.0.CO;2-C","volume":"71","author":"P Heim","year":"1997","unstructured":"Heim, P. et al. Leukodystrophy incidence in Germany. Am. J. Med. Genet. 71, 475\u2013478 (1997).","journal-title":"Am. J. Med. Genet."},{"key":"82778_CR3","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1586\/ern.11.135","volume":"11","author":"A Kohlschutter","year":"2011","unstructured":"Kohlschutter, A. & Eichler, F. Childhood leukodystrophies: a clinical perspective. Expert Rev. Neurother. 11, 1485\u20131496. https:\/\/doi.org\/10.1586\/ern.11.135 (2011).","journal-title":"Expert Rev. Neurother."},{"key":"82778_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ymgme.2015.01.006","volume":"114","author":"A Vanderver","year":"2015","unstructured":"Vanderver, A. et al. Case definition and classification of leukodystrophies and leukoencephalopathies. Mol. Genet. Metab. 114, 494\u2013500. https:\/\/doi.org\/10.1016\/j.ymgme.2015.01.006 (2015).","journal-title":"Mol. Genet. Metab."},{"key":"82778_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1148\/radiology.213.1.r99se01121","volume":"213","author":"MS van der Knaap","year":"1999","unstructured":"van der Knaap, M. S., Breiter, S. N., Naidu, S., Hart, A. A. & Valk, J. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 213, 121\u2013133. https:\/\/doi.org\/10.1148\/radiology.213.1.r99se01121 (1999).","journal-title":"Radiology"},{"key":"82778_CR6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/ana.24650","volume":"79","author":"A Vanderver","year":"2016","unstructured":"Vanderver, A. et al. Whole exome sequencing in patients with white matter abnormalities. Ann. Neurol. 79, 1031\u20131037. https:\/\/doi.org\/10.1002\/ana.24650 (2016).","journal-title":"Ann. Neurol."},{"key":"82778_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1055\/s-0036-1584602","volume":"47","author":"JJ Boelens","year":"2016","unstructured":"Boelens, J. J. & van Hasselt, P. M. Neurodevelopmental outcome after hematopoietic cell transplantation in inborn errors of metabolism: current considerations and future perspectives. Neuropediatrics 47, 285\u2013292. https:\/\/doi.org\/10.1055\/s-0036-1584602 (2016).","journal-title":"Neuropediatrics"},{"key":"82778_CR8","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","volume":"377","author":"F Eichler","year":"2017","unstructured":"Eichler, F. et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N. Engl. J. Med. 377, 1630\u20131638. https:\/\/doi.org\/10.1056\/NEJMoa1700554 (2017).","journal-title":"N. Engl. J. Med."},{"key":"82778_CR9","doi-asserted-by":"publisher","first-page":"106448","DOI":"10.1016\/j.clineuro.2020.106448","volume":"201","author":"N Mahdieh","year":"2020","unstructured":"Mahdieh, N. et al. Novel disease-causing variants in a cohort of Iranian patients with metachromatic leukodystrophy and in silico analysis of their pathogenicity. Clin. Neurol. Neurosurg. 201, 106448. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106448 (2020).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"82778_CR10","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/ajmg.a.61641","volume":"182","author":"JL Schmidt","year":"2020","unstructured":"Schmidt, J. L. et al. Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing. Am. J. Med. Genet. Part A 182, 1906\u20131912. https:\/\/doi.org\/10.1002\/ajmg.a.61641 (2020).","journal-title":"Am. J. Med. Genet. Part A"},{"key":"82778_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/acn3.50957","volume":"7","author":"G Helman","year":"2020","unstructured":"Helman, G. et al. Genome sequencing in persistently unsolved white matter disorders. Ann. Clin. Transl. Neurol. 7, 144\u2013152. https:\/\/doi.org\/10.1002\/acn3.50957 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"82778_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","volume":"4","author":"FM Platt","year":"2018","unstructured":"Platt, F. M., d\u2019Azzo, A., Davidson, B. L., Neufeld, E. F. & Tifft, C. J. Lysosomal storage diseases. Nat. Rev. Dis. Primers 4, 27. https:\/\/doi.org\/10.1038\/s41572-018-0025-4 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"82778_CR13","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","volume":"118","author":"WP Miller","year":"2011","unstructured":"Miller, W. P. et al. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood 118, 1971\u20131978. https:\/\/doi.org\/10.1182\/blood-2011-01-329235 (2011).","journal-title":"Blood"},{"key":"82778_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11064-018-2693-6","volume":"45","author":"D Pleasure","year":"2020","unstructured":"Pleasure, D. et al. Pathophysiology and treatment of canavan disease. Neurochem. Res. 45, 561\u2013565. https:\/\/doi.org\/10.1007\/s11064-018-2693-6 (2020).","journal-title":"Neurochem. Res."},{"key":"82778_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1212\/01.wnl.0000284828.84464.35","volume":"70","author":"M Henneke","year":"2008","unstructured":"Henneke, M. et al. GJA12 mutations are a rare cause of Pelizaeus\u2013Merzbacher-like disease. Neurology 70, 748\u2013754. https:\/\/doi.org\/10.1212\/01.wnl.0000284828.84464.35 (2008).","journal-title":"Neurology"},{"key":"82778_CR16","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1093\/brain\/awv204","volume":"138","author":"A Lossos","year":"2015","unstructured":"Lossos, A. et al. Myelin-associated glycoprotein gene mutation causes Pelizaeus\u2013Merzbacher disease-like disorder. Brain J. Neurol. 138, 2521\u20132536. https:\/\/doi.org\/10.1093\/brain\/awv204 (2015).","journal-title":"Brain J. Neurol."},{"key":"82778_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1006\/bbrc.1994.1979","volume":"202","author":"S Kemp","year":"1994","unstructured":"Kemp, S. et al. Identification of a two base pair deletion in five unrelated families with adrenoleukodystrophy: a possible hot spot for mutations. Biochem. Biophys. Res. Commun. 202, 647\u2013653. https:\/\/doi.org\/10.1006\/bbrc.1994.1979 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"82778_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/ejpn.1999.0256","volume":"4","author":"PL Rady","year":"2000","unstructured":"Rady, P. L., Penzien, J. M., Vargas, T., Tyring, S. K. & Matalon, R. Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease. Eur. J. Paediatr. Neurol.  4, 27\u201330. https:\/\/doi.org\/10.1053\/ejpn.1999.0256 (2000).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"82778_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1023\/a:1005512524957","volume":"22","author":"ON Elpeleg","year":"1999","unstructured":"Elpeleg, O. N. & Shaag, A. The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients. J. Inherit. Metab. Dis. 22, 531\u2013534. https:\/\/doi.org\/10.1023\/a:1005512524957 (1999).","journal-title":"J. Inherit. Metab. Dis."},{"key":"82778_CR20","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/ajmg.a.33932","volume":"155A","author":"N Kaya","year":"2011","unstructured":"Kaya, N. et al. GM2 gangliosidosis in Saudi Arabia: multiple mutations and considerations for future carrier screening. Am. J. Med. Genet. Part A 155A, 1281\u20131284. https:\/\/doi.org\/10.1002\/ajmg.a.33932 (2011).","journal-title":"Am. J. Med. Genet. Part A"},{"key":"82778_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00439-002-0682-x","volume":"110","author":"PA Leegwater","year":"2002","unstructured":"Leegwater, P. A. et al. Identification of novel mutations in MLC1 responsible for megalencephalic leukoencephalopathy with subcortical cysts. Hum. Genet. 110, 279\u2013283. https:\/\/doi.org\/10.1007\/s00439-002-0682-x (2002).","journal-title":"Hum. Genet."},{"key":"82778_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.blre.2016.07.001","volume":"30","author":"N Mahdieh","year":"2016","unstructured":"Mahdieh, N. & Rabbani, B. Beta thalassemia in 31,734 cases with HBB gene mutations: pathogenic and structural analysis of the common mutations; Iran as the crossroads of the Middle East. Blood Rev. 30, 493\u2013508. https:\/\/doi.org\/10.1016\/j.blre.2016.07.001 (2016).","journal-title":"Blood Rev."},{"key":"82778_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30 (2015).","journal-title":"Genet. Med."},{"key":"82778_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248\u2013249. https:\/\/doi.org\/10.1038\/nmeth0410-248 (2010).","journal-title":"Nat. Methods"},{"key":"82778_CR25","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886\u2013D894. https:\/\/doi.org\/10.1093\/nar\/gky1016 (2019).","journal-title":"Nucleic Acids Res."},{"key":"82778_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz, J. M., Cooper, D. N., Schuelke, M. & Seelow, D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat. Methods 11, 361\u2013362. https:\/\/doi.org\/10.1038\/nmeth.2890 (2014).","journal-title":"Nat. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82778-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82778-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82778-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:17:54Z","timestamp":1670037474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82778-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["82778"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-82778-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"7 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3231"}}